A
ANI Pharmaceuticals, Inc. (ANIP)
72.82
0.00 (0.00%)

72.82
0.00 (0.00%)
This stock has a consensus price target of $95.50 based on the ratings of 11 analysts. The high is $124.00 and the low is $68.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 68 | $ 95.5 | $ 124 |
| O’zgarish | -6.62% | 31.15% | 70.28% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-01-16 | 70.28% | Guggenheim | $115 → $124 | Maintains | Buy |
| 2025-12-09 | 37.32% | Barclays | $100 | Initiates Coverage On | Overweight |
| 2025-11-10 | 57.92% | Guggenheim | $114 → $115 | Maintains | Buy |
| 2025-10-09 | 23.59% | Truist Securities | $77 → $90 | Maintains | Hold |
| 2025-09-24 | 57.92% | JP Morgan | $95 → $115 | Maintains | Overweight |